KRAS and colorectal carcinoma: We identified that mutated KRAS regulated asparagine synthetase (ASNS), an enzyme that is involved in de novo synthesis of asparagine from aspartate, and that KRAS-mutant CRC cells could become adaptive to glutamine depletion through ASNS-dependent asparagine biosynthesis.